» Articles » PMID: 23720258

Obstructive Sleep Apnea

Overview
Journal Compr Physiol
Specialty Physiology
Date 2013 May 31
PMID 23720258
Citations 59
Authors
Affiliations
Soon will be listed here.
Abstract

Obstructive sleep apnea (OSA) is a common disorder characterized by repetitive collapse of the pharyngeal airway during sleep. Control of pharyngeal patency is a complex process relating primarily to basic anatomy and the activity of many pharyngeal dilator muscles. The control of these muscles is regulated by a number of processes including respiratory drive, negative pressure reflexes, and state (sleep) effects. In general, patients with OSA have an anatomically small airway the patency of which is maintained during wakefulness by reflex-driven augmented dilator muscle activation. At sleep onset, muscle activity falls, thereby compromising the upper airway. However, recent data suggest that the mechanism of OSA differs substantially among patients, with variable contributions from several physiologic characteristics including, among others: level of upper airway dilator muscle activation required to open the airway, increase in chemical drive required to recruit the pharyngeal muscles, chemical control loop gain, and arousal threshold. Thus, the cause of sleep apnea likely varies substantially between patients. Other physiologic mechanisms likely contributing to OSA pathogenesis include falling lung volume during sleep, shifts in blood volume from peripheral tissues to the neck, and airway edema. Apnea severity may progress over time, likely due to weight gain, muscle/nerve injury, aging effects on airway anatomy/collapsibility, and changes in ventilatory control stability.

Citing Articles

Acetazolamide as an Add-on Therapy Following Barbed Reposition Pharyngoplasty in Obstructive Sleep Apnea: A Randomized Controlled Trial.

Hellemans S, Van de Perck E, Van Loo D, Verbraecken J, Sands S, Azarbarzin A Life (Basel). 2024; 14(8).

PMID: 39202705 PMC: 11355526. DOI: 10.3390/life14080963.


Pharmacological interventions for the treatment of obstructive sleep apnea syndrome.

Liu J, Yang X, Li G, Liu P Front Med (Lausanne). 2024; 11:1359461.

PMID: 38495117 PMC: 10943699. DOI: 10.3389/fmed.2024.1359461.


Cardiovascular Disease Outcomes Associated with Obstructive Sleep Apnea in Diabetics: A Systematic Review and Meta-Analysis.

Bushi G, Padhi B, Shabil M, Satapathy P, Rustagi S, Pradhan K Diseases. 2023; 11(3).

PMID: 37606474 PMC: 10443251. DOI: 10.3390/diseases11030103.


Hypoxic Burden Based on Automatically Identified Desaturations Is Associated with Adverse Health Outcomes.

Esmaeili N, Labarca G, Hu W, Vena D, Messineo L, Gell L Ann Am Thorac Soc. 2023; 20(11):1633-1641.

PMID: 37531573 PMC: 10632930. DOI: 10.1513/AnnalsATS.202303-248OC.


Optical and pharmacological manipulation of hypoglossal motor nucleus identifies differential effects of taltirelin on sleeping tonic motor activity and responsiveness.

Aggarwal J, Ladha R, Liu W, Liu H, Horner R Sci Rep. 2023; 13(1):12299.

PMID: 37516800 PMC: 10387086. DOI: 10.1038/s41598-023-39562-z.